Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    CAS 6282-60-6 manufacturers and suppliers on PharmaCompass

    Client Email Product

    CAS 6282-60-6

    Manufacturers/Suppliers

    PharmaCompass
    CAS 6282-60-6
    Also known as: 6282-60-6, Nsc7059, Dtxsid50278358, Nsc-7059, Zinc1566575
    Molecular Formula
    C15H28O2
    Molecular Weight
    240.38  g/mol
    InChI Key
    MQMJSIDAUWCUJP-UHFFFAOYSA-N
    1 2D Structure

    CAS 6282-60-6

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    3-butyl-3-ethyl-1,5-dioxaspiro[5.5]undecane
    2.1.2 InChI
    InChI=1S/C15H28O2/c1-3-5-9-14(4-2)12-16-15(17-13-14)10-7-6-8-11-15/h3-13H2,1-2H3
    2.1.3 InChI Key
    MQMJSIDAUWCUJP-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCCCC1(COC2(CCCCC2)OC1)CC
    2.2 Synonyms
    2.2.1 Depositor-Supplied Synonyms

    1. 6282-60-6

    2. Nsc7059

    3. Dtxsid50278358

    4. Nsc-7059

    5. Zinc1566575

    2.3 Create Date
    2005-03-26
    3 Chemical and Physical Properties
    Molecular Weight 240.38 g/mol
    Molecular Formula C15H28O2
    XLogP34.4
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count2
    Rotatable Bond Count4
    Exact Mass g/mol
    Monoisotopic Mass g/mol
    Topological Polar Surface Area18.5
    Heavy Atom Count17
    Formal Charge0
    Complexity221
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    ListList of Suppliers
    Full View ScreenFull Screen View
    refresh Reset Filter
    refresh Reset Filter
    price-trend Ask Us

    ICE Pharma

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Lithocholic acid

    PDF Supplier PDF
    URL Supplier Web Content
    434-13-9
    Ursodeoxycholic Acid
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most import...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    CPhI Worldwide, Milan

    Booth #4A41

    envelop Contact Supplier

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    famar-2024-07-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search